EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A one health perspective on the intestinal microbiome's role in COVID-19 outcomes and recovery

Pallavi Singh, Anitha Saravanan, Jeanine Seitz, Nour Alkarzon, Nubwa Medugu

Frontiers in Cellular and Infection Microbiology · 19.05.2026 · 16

DOI: 10.3389/fcimb.2026.1763844 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 19.05.2026. Verfasst von Pallavi Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Northern Illinois University, DeKalb, IL, United States. Hauptthemen laut MEDLINE: COVID-19, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging infectious diseases, particularly zoonotic ones, remain major global health concerns. The Coronavirus Disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), highlights the interconnectedness of human, animal, and environmental health within the One Health framework. The intestinal microbiome plays a central role in host immunity and systemic homeostasis, and its disruption has been linked to altered disease severity and recovery patterns in COVID-19. Evidence suggests that SARS-CoV-2 infection induces intestinal dysbiosis, modifies immune signaling, and affects the microbiota-gut-brain axis (MGBA), contributing to neuropsychiatric and metabolic complications. This review synthesizes current findings on the intestinal microbiome’s role in COVID-19 pathophysiology and recovery, explores emerging therapeutic strategies including probiotics, prebiotics, and fecal microbiota transplantation, and emphasizes the importance of integrating microbiome research into pandemic preparedness through a One Health approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Gastrointestinal MicrobiomeHumansDysbiosisSARS-CoV-2AnimalsFecal Microbiota TransplantationProbioticsPrebioticsPandemics

Stichwörter der Autor:innen

One Health frameworkSARS-CoV-2/COVID-19gut dysbiosisintestinal microbiomemicrobiota-gut-brain axis (MGBA)

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Biological Sciences, Northern Illinois University, DeKalb, IL, United States.
  • School of Nursing, Northern Illinois University, DeKalb, IL, United States.
  • Department of Medical Microbiology and Immunology, Nile University of Nigeria, Abuja, Nigeria.

Zitieren

APA

Singh, P., Saravanan, A., Seitz, J., Alkarzon, N., & Medugu, N. (2026). A one health perspective on the intestinal microbiome's role in COVID-19 outcomes and recovery. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1763844

Vancouver

Singh P, Saravanan A, Seitz J, Alkarzon N, Medugu N. A one health perspective on the intestinal microbiome's role in COVID-19 outcomes and recovery. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1763844

BibTeX
@article{Singh2026,
  author = {Singh, Pallavi and Saravanan, Anitha and Seitz, Jeanine and Alkarzon, Nour and Medugu, Nubwa},
  title = {A one health perspective on the intestinal microbiome's role in COVID-19 outcomes and recovery},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1763844}
}
Kostenlos starten →